What is Asia Green Biotechnology Corp. (ASIA.CN)?

Asia Green Biotechnology Corp. (ASIA.CN) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

Asia Green Biotechnology Corp. (ASIA.CN)

Stock analysis · CNQ · Healthcare · Drug Manufacturers - Specialty & Generic

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.44

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Asia Green Biotechnology Corp. (ASIA.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Asia Green Biotechnology Corp.

Asia Green Biotechnology Corp. is an emerging international biotechnology firm dedicated to researching, developing, testing, and distributing products. These offerings leverage the company's proprietary organic hybridization technology, with its primary application focused in Asia. A key aspect of their operations involves the cultivation and harvesting of novel and commercially valuable strains of hemp and similar crops. The company has forged strategic alliances with Pathway Rx Inc. and PNW Biosciences Inc. to advance the clinical development and market introduction of specific Cannabis sativa varieties. These varieties are being explored for their potential in both preventing and treating COVID-19 and other infectious ailments. Established in 2017, the organization was originally named Asia Cannabis Corp. It adopted its current moniker, Asia Green Biotechnology Corp., in April 2020. Its corporate headquarters are located in Calgary, Canada.